4.5 Review

Marfan Syndrome and Related Disorders: 25 Years of Gene Discovery

期刊

HUMAN MUTATION
卷 37, 期 6, 页码 524-531

出版社

WILEY
DOI: 10.1002/humu.22977

关键词

thoracic aortic aneurysm; Marfan syndrome; MFS; Loeys-Dietz syndrome; LDS; TGF-beta signaling; FBN1; TGFBR1; TGFBR2; SMAD2; SMAD3; TGFB2; TGFB3; SKI

资金

  1. University of Antwerp (Lanceringsproject)
  2. Fund for Scientific Research, Flanders (FWO, Belgium) [G.0221.12]
  3. Dutch Heart Foundation [2013T093]
  4. European Research Council [ERC- StG-2012-30972-BRAVE]
  5. Fondation Leducq (MIBAVA) [Leducq 12CVD03]

向作者/读者索取更多资源

Marfan syndrome (MFS) is a rare, autosomal-dominant, multisystem disorder, presenting with skeletal, ocular, skin, and cardiovascular symptoms. Significant clinical overlap with other systemic connective tissue diseases, including Loeys-Dietz syndrome (LDS), Shprintzen-Goldberg syndrome (SGS), and the MASS phenotype, has been documented. In MFS and LDS, the cardiovascular manifestations account for the major cause of patient morbidity and mortality, rendering them the main target for therapeutic intervention. Over the past decades, gene identification studies confidently linked the aforementioned syndromes, as well as nonsyndromic aneurysmal disease, to genetic defects in proteins related to the transforming growth factor (TGF)-beta pathway, greatly expanding our knowledge on the disease mechanisms and providing us with novel therapeutic targets. As a result, the focus of the developing pharmacological treatment strategies is shifting from hemodynamic stress management to TGF-beta antagonism. In this review, we discuss the insights that have been gained in the molecular biology of MFS and related disorders over the past 25 years. (C) 2016 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Immunology

Hide and seek: Somatic SMAD3 mutations in melorheostosis

Joe Davis Velchev, Aline Verstraeten, Bart Loeys

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

iPSC-Cardiomyocyte Models of Brugada Syndrome-Achievements, Challenges and Future Perspectives

Aleksandra Nijak, Johan Saenen, Alain J. Labro, Dorien Schepers, Bart L. Loeys, Maaike Alaerts

Summary: Brugada syndrome is an inherited cardiac arrhythmia that can lead to ventricular fibrillation and sudden cardiac death. The use of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offers new opportunities for studying complex cardiac arrhythmia syndromes. iPSC-CMs are considered the best in vitro model for researching Brugada syndrome and other arrhythmias.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Genetics & Heredity

A human importin-β-related disorder: Syndromic thoracic aortic aneurysm caused by bi-allelic loss-of-function variants in IPO8

Ilse Van Gucht, Josephina A. N. Meester, Jotte Rodrigues Bento, Maaike Bastiaansen, Jarl Bastianen, Ilse Luyckx, Lotte Van den Heuvel, Cedric H. G. Neutel, Pieter-Jan Guns, Mandy Vermont, Erik Fransen, Melanie H. A. M. Perik, Joe Davis Velchev, Maaike Alaerts, Dorien Schepers, Silke Peeters, Isabel Pintelon, Abdulrahman Almesned, Matteo P. Ferla, Jenny C. Taylor, Anthony R. Dallosso, Maggie Williams, Julie Evans, Jill A. Rosenfeld, Thierry Sluysmans, Desiderio Rodrigues, Ashish Chikermane, Gangadhara Bharmappanavara, Kayal Vijayakumar, Hassan Mottaghi Moghaddam Shahri, Narges Hashemi, Paria Najarzadeh Torbati, Mehran B. Toosi, Zuhair N. Al-Hassnan, Julie Vogt, Nicole Revencu, Isabelle Maystadt, Erin M. Miller, K. Nicole Weaver, Amber Begtrup, Henry Houlden, David Murphy, Reza Maroofian, Alistair T. Pagnamenta, Lut Van Laer, Bart L. Loeys, Aline Verstraeten

Summary: Importin 8, encoded by IPO8, is crucial for the development of thoracic aortic aneurysm (TAA) and its loss-of-function variants may cause a syndromic form of TAA with clinical overlap with other syndromes. Importin 8 plays a role in dysregulation of the TGF-beta signaling pathway, providing potential for future mechanistic studies and drug targeting in TAA.

AMERICAN JOURNAL OF HUMAN GENETICS (2021)

Review Cardiac & Cardiovascular Systems

Progress in aorta and peripheral cardiovascular disease research

Lucia Mazzolai, Adriano Alatri, Alessandra Bura Riviere, Marco De Carlo, Christian Heiss, Christine Espinola-Klein, Oliver Schlager, Henrik Sillesen, Daniel Staub, Jose F. Rodriguez-Palomares, Aline Verstraeten, Victor Aboyans

Summary: This review article summarizes key research on vascular diseases published in 2020, including studies on aortic aneurysm, fibromuscular dysplasia (FMD), the role of NADPH oxidases in vascular physiology, imaging of vulnerable plaque, and clinical trials on lower extremity peripheral artery disease.

CARDIOVASCULAR RESEARCH (2021)

Article Biochemistry & Molecular Biology

Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings

Ilse Van Gucht, Alice Krebsova, Birgitte Rode Diness, Steven Laga, Dave Adlam, Marlies Kempers, Nilesh J. Samani, Tom R. Webb, Ania A. Baranowska, Lotte van den Heuvel, Melanie Perik, Ilse Luyckx, Nils Peeters, Pavel Votypka, Milan Macek, Josephina Meester, Lut Van Laer, Aline Verstraeten, Bart L. Loeys

Summary: This study found that patients with LOX gene variants have a spectrum of aortic and arterial aneurysmal diseases, often combined with connective tissue abnormalities. Some patients developed TAAD in early life, while others had normal aortic diameters in advanced age.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Genetics & Heredity

Two novel presentations of KCNMA1-related pathology--Expanding the clinical phenotype of a rare channelopathy

Jotte Rodrigues Bento, Candice Feben, Marlies Kempers, Maartje Rij, Mallory Woiski, Koenraad Devriendt, Luc De Catte, Marcella Baldewijns, Maaike Alaerts, Josephina Meester, Aline Verstraeten, Willy Hendson, Bart Loeys

Summary: The study identifies pathogenic mutations in KCNMA1 gene associated with a wide range of clinical manifestations, including aortic dilatation, growth retardation, and neurological dysfunction. The p.Gly375Arg variant is linked to aortic root dilatation, gingival hypertrophy, and neonatal overgrowth, while the p.Pro805Leu variant is associated with severe neurological manifestations.

MOLECULAR GENETICS & GENOMIC MEDICINE (2021)

Article Medicine, Research & Experimental

A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity

Annemieke Smet, Tom Breugelmans, Johan Michiels, Kevin Lamote, Wout Arras, Joris G. De Man, Leo Heyndrickx, Anne Hauner, Manon Huizing, Surbhi Malhotra-Kumar, Martin Lammens, An Hotterbeekx, Samir Kumar-Singh, Aline Verstraeten, Bart Loeys, Veronique Verhoeven, Rita Jacobs, Karolie Dams, Samuel Coenen, Kevin K. Arien, Philippe G. Jorens, Benedicte Y. De Winter

Summary: By analyzing the expression profiles of mucins in COVID-19 patients, it is possible to improve diagnosis, assess disease severity, and guide treatment options. The mucin mRNA signature can accurately differentiate the severity of the disease among patients and is associated with clinical parameters such as symptoms and organ failure.

JCI INSIGHT (2021)

Review Genetics & Heredity

The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2

Silke Peeters, Pauline De Kinderen, Josephina A. N. Meester, Aline Verstraeten, Bart L. Loeys

Summary: This article explores the phenotypic and molecular similarities between Marfan syndrome and acromelic dysplasias caused by pathogenic variants in the FBN1 and FBN2 genes. The parallel functional study of these disorders may provide insights into the effects of fibrillin variants on the microfibril network and growth factor homeostasis, leading to the development of new therapeutic approaches.

HUMAN MUTATION (2022)

Article Cardiac & Cardiovascular Systems

Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy

Hanne M. Boen, Bart L. Loeys, Maaike Alaerts, Johan B. Saenen, Inge Goovaerts, Lut Van Laer, Anne Vorlat, Tom Vermeulen, Constantijn Franssen, Patrick Pauwels, Inez Rodrigus, Hein Heidbuchel, Emeline M. Van Craenenbroeck

Summary: The study investigates the yield and importance of genetic testing in heart transplant patients with non-ischemic cardiomyopathy. The results show that genetic testing in these patients can establish a molecular diagnosis and is recommended for identifying at-risk relatives, regardless of family history or second precipitating factors.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cell & Tissue Engineering

Generation and validation of an iPSC line (BBANTWi008-A) from a Loeys-Dietz Syndrome type 3 patient

Joe Davis Velchev, Aline Verstraeten, Josephina Meester, Peter Ponsaerts, Julie Richer, Maaike Alaerts, Bart Loeys

Summary: This study generated an induced pluripotent stem cell line from a severely affected Loeys-Dietz Syndrome patient and demonstrated its pluripotency, providing a valuable tool for studying and targeting the cellular mechanisms of SMAD3-related LDS.

STEM CELL RESEARCH (2022)

Editorial Material Cardiac & Cardiovascular Systems

The emerging role of endothelial cells in the pathogenesis of thoracic aortic aneurysm and dissection

Aline Verstraeten, Ivanna Fedoryshchenko, Bart Loeys

EUROPEAN HEART JOURNAL (2023)

Review Genetics & Heredity

SMAD6-deficiency in human genetic disorders

Ilse Luyckx, Aline Verstraeten, Marie-Jose Goumans, Bart Loeys

Summary: This article reviews the clinical and genetic similarities of three diseases related to SMAD6, compares mouse models, and discusses the cellular mechanisms of SMAD6 in the development of these diseases. The importance of further research to improve molecular diagnosis, advance therapeutic strategies, and provide counseling for patients and their families is also emphasized.

NPJ GENOMIC MEDICINE (2022)

Review Biochemistry & Molecular Biology

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development

Eline Simons, Bart Loeys, Maaike Alaerts

Summary: The discovery of induced pluripotent stem cells has allowed the generation of various cell types, including iPSC-derived cardiomyocytes, for different purposes such as disease modelling and drug discovery. While 2D iPSC-CM models have shown promise, they are less mature compared to adult cardiomyocytes. Novel approaches are being developed to create 3D models with added cell types, improving maturity and physiological relevance. This review focuses on the progress in modelling inherited cardiac arrhythmias using both 2D and 3D models, and their application in therapy development and drug testing.

BIOMEDICINES (2023)

Article Cell & Tissue Engineering

A generated induced pluripotent stem cell (iPSC) line (CMGANTi005-A) of a Marfan syndrome patient with an FBN1 c.7754T > C (p. Ile2585Thr) variation

Lotte J. F. Van Den Heuvel, Silke Peeters, Josephina A. N. Meester, Melanie Perik, Paul Coucke, Bart L. Loeys

Summary: Marfan syndrome is a connective tissue disorder characterized by manifestations in the ocular, skeletal, and cardiovascular system, often caused by pathogenic variants in the FBN1 gene. We have generated an induced pluripotent cell (iPSC) line from a Marfan syndrome patient with an FBN1 c.7754T > C (p. Ile2585Thr) variant. The iPSC line derived from peripheral blood mononuclear cells showed no copy number alterations, expressed pluripotency markers, and could differentiate into three germ layers while maintaining the original genotype.

STEM CELL RESEARCH (2023)

Article Cell & Tissue Engineering

Generation of an induced pluripotent stem cell (iPSC) line of a Marfan syndrome patient with a pathogenic FBN1 c.5372G > A (p. Cys1791Tyr) variant

Silke Peeters, Ivanna Fedoryshchenko, Laura Rabaut, Aline Verstraeten, Bart L. Loeys

Summary: Marfan syndrome (MFS) is a connective tissue disorder that affects the ocular, skeletal, and cardiovascular systems. It is caused by pathogenic variants in the FBN1 gene. This study successfully generated an induced pluripotent cell (iPSC) line from a MFS patient carrying a FBN1 c.5372G > A (p.Cys1791Tyr) variant. The iPSCs exhibited normal characteristics and maintained the original genotype.

STEM CELL RESEARCH (2023)

暂无数据